M&T Bank’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,939
Closed -$475K 1720
2022
Q3
$475K Sell
1,939
-82
-4% -$22.1K ﹤0.01% 1108
2022
Q2
$479K Buy
2,021
+174
+9% +$47K ﹤0.01% 1028
2022
Q1
$611K Buy
1,847
+214
+13% +$65.9K ﹤0.01% 910
2021
Q4
$586K Sell
1,633
-1
-0.1% -$338 ﹤0.01% 959
2021
Q3
$533K Sell
1,634
-4
-0.2% -$1.35K ﹤0.01% 982
2021
Q2
$512K Buy
1,638
+14
+0.9% +$4.29K ﹤0.01% 1026
2021
Q1
$519K Sell
1,624
-593
-27% -$190K ﹤0.01% 982
2020
Q4
$719K Buy
2,217
+51
+2% +$14.1K ﹤0.01% 898
2020
Q3
$600K Sell
2,166
-56
-3% -$16.1K ﹤0.01% 893
2020
Q2
$536K Buy
2,222
+465
+26% +$93.4K ﹤0.01% 911
2020
Q1
$255K Buy
1,757
+158
+10% +$26.2K ﹤0.01% 1215
2019
Q4
$273K Sell
1,599
-207
-11% -$38.4K ﹤0.01% 1136
2019
Q3
$321K Sell
1,806
-395
-18% -$85.4K ﹤0.01% 1162
2019
Q2
$573K Buy
2,201
+296
+16% +$78.5K ﹤0.01% 924
2019
Q1
$545K Buy
1,905
+328
+21% +$109K ﹤0.01% 917
2018
Q4
$514K Buy
1,577
+20
+1% +$6.95K ﹤0.01% 899
2018
Q3
$701K Buy
1,557
+278
+22% +$110K ﹤0.01% 882
2018
Q2
$523K Sell
1,279
-76
-6% -$27.5K ﹤0.01% 989
2018
Q1
$394K Buy
1,355
+171
+14% +$43.3K ﹤0.01% 1097
2017
Q4
$221K Sell
1,184
-113
-9% -$21.1K ﹤0.01% 1389
2017
Q3
$219K Buy
+1,297
New +$196K ﹤0.01% 1377
2016
Q3
Sell
-3,445
Closed -$377K 1789
2016
Q2
$377K Sell
3,445
-854
-20% -$85K ﹤0.01% 1145
2016
Q1
$408K Buy
+4,299
New +$363K ﹤0.01% 1135
2015
Q3
Sell
-20,615
Closed -$1.35M 2064
2015
Q2
$1.35M Buy
20,615
+5,283
+34% +$351K 0.01% 756
2015
Q1
$1.1M Buy
15,332
+78
+0.5% +$4.23K 0.01% 827
2014
Q4
$581K Sell
15,254
-5,863
-28% -$185K ﹤0.01% 1123
2014
Q3
$524K Buy
+21,117
New +$535K ﹤0.01% 1235

Other funds holding ABMD

M&T Bank's ABMD Position: Q4 2022 in Review

M&T Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,939 shares — an estimated $475K sold.

M&T Bank first reported a position in ABMD in Q3 2014 and held it in 27 quarters. The position peaked at $1.35M in Q2 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • M&T Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • M&T Bank sold 1,939 Abiomed Inc shares in Q4 2022, an estimated $475K.
  • M&T Bank first reported a position in Abiomed Inc in Q3 2014 and held it in 27 quarters.
  • M&T Bank's Abiomed Inc position peaked at $1.35M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on M&T Bank's 13F filing for Q4 2022, filed 13 Feb 2023.